517MO Phase I study of the porcupine (PORCN) inhibitor RXC004 in patients with advanced solid tumours

Autor:	A. Ortego Franco, L. Goodwin, Ruth Plummer, Natalie Cook, Juanita Lopez, Alastair Greystoke, Rille Pihlak, A. Naderi, G. Nintos, Debashis Sarker, C. Tilston, F. Kazmi, S. Blagden, C. Phillips, S. Woodcock, R. Shinde, A. Saunders, John F.R. Robertson, N. Harris
Rok vydání:	2021
Předmět:	Oncology biology business.industry biology.animal Cancer research Medicine In patient Hematology business Porcupine Phase i study PORCN
Zdroj:	Annals of Oncology. 32:S586-S587
ISSN:	0923-7534
DOI:	10.1016/j.annonc.2021.08.1039
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::77908609a345543b8f227592b9cf35a3 https://doi.org/10.1016/j.annonc.2021.08.1039 Zobrazit plný text záznamu